ReviewDiagnostics (Basel, Switzerland)2023
Arrhythmic Risk and Treatment after Transcatheter Atrial Septal Defect Closure.
Review in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 8 citations in OpenAlex.
- Complications after percutaneous device closure of atrial septal defects in children: Prevalence, outcomes and associated factors.International journal of cardiology. Congenital heart disease · 2026Article
- Late-Onset Perinodal Atrial Tachycardia After Transcatheter Atrial Septal Device Closure.JACC. Case reports · 2026Article
- Recurrent atrial fibrillation and stroke in a young adult with congenital heart defects: A case report.Medicine · 2026Article
- Preferred age for beating-heart atrial septal defect repair via right subaxillary mini-incision in pediatric patients.Journal of cardiothoracic surgery · 2026Article
- Successful radiofrequency catheter ablation of right-sided focal atrial tachycardia in a patient with Holt-Oram syndrome: a case report.Frontiers in cardiovascular medicine · 2026Article
- Short-term outcomes of atrial septal defect repair via right axillary incision in children: a single-center propensity-matched analysis.BMC surgery · 2025Article
- Can Artificial Intelligence Revolutionize the Diagnosis and Management of the Atrial Septal Defect in Children?Diagnostics (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrial septal defect (ASD) represents the most common congenital heart defect identified in adulthood. Atrial and ventricular geometric remodeling due to intracardiac shunt increase the risk of arrhythmias, especially atrial fibrillation (AF). Clinical, echocardiography, electrocardiogram, and device-related predictors may be used to assess the risk of atrial arrhythmias after ASD closure. The underlying mechanisms in these patients are complex and at least in part independent of the structural remodeling secondary to hemodynamic overload. Device closure of the ASD itself and its timing impact future arrhythmia risk, as well as posing a challenge for when transseptal puncture is required. Sudden cardiac death (SCD) risk is higher than in the general population and an implantable cardioverter-defibrillator (ICD) may be indicated in selected cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.